Lack of Association between Polymorphisms in Inflammatory Genes and Lung Cancer Risk
Open Access
- 1 February 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 14 (2) , 538-539
- https://doi.org/10.1158/1055-9965.epi-04-0513
Abstract
IL-6 is a major cytokine that is expressed in tumor-infiltrating cells. Lung cancer patients have been shown to have significantly higher serum levels of IL-6 compared with healthy controls (1).Keywords
This publication has 6 references indexed in Scilit:
- Occupational Exposure to Vinyl Chloride, Acrylonitrile and Styrene and Lung Cancer Risk (Europe)Cancer Causes & Control, 2004
- Polymorphisms of the interleukin‐1 β gene are associated with increased risk of non‐small cell lung cancerInternational Journal of Cancer, 2004
- Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancerCarcinogenesis: Integrative Cancer Research, 2003
- Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokersOncology Reports, 2002
- Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive proteinCardiovascular Research, 2002
- An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancerProceedings of the National Academy of Sciences, 2001